Attached files

file filename
EX-31.1 - EX-31.1 - VALEANT PHARMACEUTICALS INTERNATIONALa55268exv31w1.htm
EX-31.2 - EX-31.2 - VALEANT PHARMACEUTICALS INTERNATIONALa55268exv31w2.htm
EX-23 - EX-23 - VALEANT PHARMACEUTICALS INTERNATIONALa55268exv23.htm
EX-3.3 - EX-3.3 - VALEANT PHARMACEUTICALS INTERNATIONALa55268exv3w3.htm
EX-32 - EX-32 - VALEANT PHARMACEUTICALS INTERNATIONALa55268exv32.htm
10-K - FORM 10-K - VALEANT PHARMACEUTICALS INTERNATIONALa55268e10vk.htm
EXHIBIT 21
VALEANT PHARMACEUTICALS INTERNATIONAL
     
SUBSIDIARIES JURISDICTION OF INCORPORATION
 
Valeant Pharmaceuticals Australasia Pty. Ltd.
  Australia
DermaTech Pty, Ltd.
  Australia
Private Formula International Holdings Pty. Limited
  Australia
Private Formula International Pty. Limited
  Australia
 
Valeant Farmaceutica do Brasil, Ltda.
  Brazil
 
Valeant Canada Holdings Ltd.
  Canada
Valeant Canada, Ltd.
  Canada
Laboratorie Dr Renaud Inc.
  Canada
 
Valeant Czech Pharma LLC
  Czech Republic
 
bioskin GmbH
  Germany
 
Valeant Pharma Hungary Commercial LLC
  Hungary
Csatarka Irodahaz Ltd.
  Hungary
 
Valeant Farmaceutica, S.A. de C.V.
  Mexico
Laboratorios Grossman, S.A.
  Mexico
Logistica Valeant, S.A. de C.V
  Mexico
Nysco de Mexico S.A. de C.V.
  Mexico
Tecnofarma, S.A. de C.V.
  Mexico
 
Valeant Dutch Holdings B.V.
  Netherlands
 
Valeant Pharmaceuticals New Zealand Limited
  New Zealand
 
Valeant Farmacuetica Panama S.A.
  Panama
 
ICN Polfa Rzeszow S.A.
  Poland
Emo-Farm spólka z ograniczoną odpowiedzialnością
  Poland
 
Valeant Development Company Pte. Ltd.
  Singapore
Valeant Singapore Pte. Ltd.
  Singapore
Valeant Global Pte. Ltd.
  Singapore
 
Valeant Slovakia s.r.o.
  Slovak Republic
 
Private Formula Corp.
  California (US)
Dr. LeWinn’s Private Formula International Inc.
  California (US)
 
Valeant Biomedicals, Inc.
  Delaware (US)
Valeant Pharmaceuticals North America
  Delaware (US)
Coria Laboratories, Ltd.
  Delaware (US)
Oceanside Pharmaceuticals, Inc.
  Delaware (US)
Dow Pharmaceuticals Sciences, Inc.
  Delaware (US)
 
Renaud Skin Care Laboratories, Inc.
  New York (US)
In accordance with the instructions of Item 601 of Regulation S-K, certain subsidiaries are omitted from the foregoing table.